Multiple endogenous cell-surface and extracellular matrix receptors

The term Multiple endogenous cell-surface and extracellular matrix receptors refers to a broad and heterogeneous group of proteins rather than a single molecular target. This classification typically encompasses various growth factor receptors (such as VEGFR, PDGFR, and FGFR), integrins, and structural components of the extracellular matrix (ECM) like heparan sulfate proteoglycans (Source: PubChem CID 5361; Cancer Treatment Reviews, 'Suramin: an anticancer drug with a unique mechanism of action'). These molecules are essential for mediating cellular communication, adhesion, and structural integrity within the tissue microenvironment. In pathological states, particularly cancer and chronic inflammation, these receptors are often dysregulated to promote tumor growth, angiogenesis, and metastasis. Drugs associated with this 'target' description, such as the polyanionic compound Suramin, exert their effects through polypharmacology by displacing natural ligands from their binding sites on multiple distinct receptors (Source: National Cancer Institute). Because this entry aggregates numerous unrelated gene products into a single functional category, it is considered an incorrect or overly broad designation for structured therapeutic target databases.

Other names

Cell-surface and ECM receptorsExtracellular matrix-associated receptorsGrowth factor and adhesion receptors

Broad-spectrum inhibition of ligand-receptor interactions by competitive binding or steric hindrance across multiple protein families.